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Influenza A virus (IAV) is a major human pathogen whose genotypic diversity results in unpredictable
pandemics and epidemics. Interaction with the cell nucleus is essential to IAV infection, allowing
recruitment of cellular components to facilitate virus replication. Viral proteins are also targeted to the
nucleolus, a subnuclear structure involved in ribosomal biogenesis, RNA maturation, stress response,
and control of cell growth, but the functional consequences of this are unclear. We took an unbiased
approach to studying IAV-nucleolar interactions by using stable isotope labeling with amino acids in
cell culture (SILAC) in conjunction with LC-MS/MS to quantify changes in the nucleolar proteome
following infection with A/PR/8/34 (H1N1) and A/Udorn/72 (H3N2) strains of the virus. Only a minority
of nucleolar proteins showed significant changes in abundance after infection; these alterations were
mostly different between the two strains but could be validated by confocal microscopy of infected
cells. Many of the affected proteins comprised functional groupings, including components of
ribonuclease P, RNA polymerase I, the MLL1 histone methyltransferase complex, as well as nuclear
paraspeckles and the RNA editing apparatus. This, as well as comparison with other viruses that cause
changes in the nucleolar proteome, suggests that IAV targets specific nucleolar pathways.
Keywords: influenza virus • nucleolus • quantitative proteomics • SILAC • LC-MS/MS • Rnase P • ADAR1
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Introduction
Influenza A virus (IAV) is one of the world’s major uncon-
trolled pathogens, causing seasonal epidemics as well as global
pandemics.1 The negative-sense RNA of the IAV genome is
divided into eight segments, and this segmentation defines
many of the characteristics of the virus. Notably, reassortment
of segments from different viruses coinfecting a single host has
been responsible for the emergence of at least three pandemic
strains within the last century.2,3 The eight IAV segments
encode 12 identified polypeptides, only two of which are
nonessential outside of the laboratory setting.4,5 Essential
structural proteins include the three subunits of an RNA-
dependent RNA polymerase (PB1, PB2 and PA) and a nucle-
oprotein (NP) that encapsidate the genomic segments into
ribonucleoprotein (RNP) complexes,6 three trans-membrane
proteins (HA, NA and M2), as well as matrix (M1) and NS2/
NEP.7 Non structural proteins include NS1, the major viral
antagonist of innate immune responses8 and the two non
essential proteins identified to date (both encoded by segment
2); PB1-N40, a truncated form of PB1, and PB1-F2, a pro-
apoptotic virulence factor.4,5
Viral RNA synthesis occurs in nuclei of infected cells.
Genome transcription produces capped and polyadenylated
mRNAs while the vRNAs are replicated via an alternative plus
sense “cRNA” intermediate.9 Although RNPs contain the mini-
mum essential viral components for these processes, multiple
cellular factors are likely to be co-opted in vivo.10,11 Viral RNA
synthesis occurs in the nucleoplasm, probably partly in as-
sociation with cellular RNA polymerase II.12 However, similarly
to many other RNA viruses,13 several influenza virus proteins,
including components of the polymerase, NP, NS1 and NEP
have been shown to localize to the nucleolus.14-18 The nucleo-
lus is a dynamic subnuclear compartment involved in riboso-
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mal subunit biogenesis, RNA processing and trafficking, regu-
lation of cell growth, and response to cell stress and is
composed of a complex network of protein-protein and
protein-nucleic acid interactions.19 There is evidence that virus
infection can cause changes in the nuclear proteome and archi-
tecture, which may regulate its function.20-22 Intriguingly, the
nucleolus in Caenorhabditis elegans has recently been implicated
in regulating innate immune responses against bacterial patho-
gens,23 but it is not yet certain whether themammalian nucleolus
plays a defensive role against viruses.
IAV infection results in perturbations to nucleolar struc-
ture,11,15,24 but the functional consequences of this, for virus or
cell, are unknown. On one hand, the nucleolus might be func-
tionally irrelevant to the virus, with viral RNA-binding proteins
coincidentally localizing to a RNA-rich compartment. Additionally,
perturbations seen to nucleolar structuremay result from indirect
effects of infection, such as cellular stress. However, a more
interesting and evolutionary plausible hypothesis holds that even
given an originally fortuitous localization of a viral protein to the
nucleolus, variants where this resulted in beneficial disruption of
nucleolar function and/or recruitment of nucleolar components
to viral processes would be selected.13,22 Consistent with this, a
recent study showing the displacement of nucleophosmin (NPM,
B23.1) from the nucleolus on IAV infection proposed a conse-
quent stimulatory effect on viral RNA synthesis.25 Further
complicating the picture of the interaction of IAV with the
nucleolus is that the nucleolar localization of viral proteins,
specifically NS1 protein, may be dependent not only on the
subtype of the virus26,27 but also on the host cell.28 For example,
the NS1 protein of the A/Udorn/72 (Udorn) strain localized to
the nucleolus in A549 cells, whereas A/Puerto Rico/8/34 (PR8)
NS1 strain did not.28 In contrast, NS1 from both viruses was
present in the nucleolus of infected duck embryonic fibroblasts.
However, study of the localization of proteins to the nucleolus
using indirect immunofluorescence is complicated by poor
antibody penetration and antigen abundance in the nucleo-
lus,29 while the addition of fluorescent tags may affect protein
localization and function.
Thus, there are many unresolved questions regarding the
interaction of IAV and the nucleolus. To further investigate this
area of virus-cell biology, we took an unbiased approach using
stable isotope labeling with amino acids in cell culture (SILAC)
in conjunction with LC-MS/MS to identify and quantify
cellular and viral proteins from purified nucleoli, following
infection with Udorn or PR8 strains of virus, compared to mock
infection. Although the virus strain exerted a large influence
on the outcome, only a minority of cellular proteins showed
substantial changes in abundance after infection. Furthermore,
clear functional groupings of many of the affected proteins were
evident, including components of ribonuclease P, RNA poly-
merase I, the MLL1 complex, as well as nuclear paraspeckles
and the RNA editing apparatus. Overall, our data support the
hypothesis of specific functional interactions between IAV and
the nucleolus, rather than a global change in nucleolar integrity.
Experimental Procedures
Virus Growth. Human embryonic kidney 293-T cells30 were
cultured as previously described.31 For viruses, a variant of the
National Institute for Biological Standards and Control (UK)
strain of PR8 virus that had been further adapted for growth
in MDCK cells before cloning32 and a filamentous lineage of
Udorn virus (A/Udorn/301/72)33,34 were used. Both viruses
replicate productively in 293-T cells.35 Virus stocks were grown
in embryonated eggs and titerd as previously described.36 Virus
infections were carried out at an MOI of 5 and uninfected
allantoic fluid was used for mock infections. All work with
infectious virus was carried out at Biosafety Level 2 (BSL-2).
Plasmids and Transfection. Adherent subconfluent 293-T
cells were transfected on glass coverslips with 800 ng of phPOP1
(which expresses a vesicular stomatitis virus-tagged protein, a
kind gift from G. Prujin37) using 1 µL of Lipofectamine 2000
(Invitrogen) in Optimem (Invitrogen). The next day, the cells
were infected or mock infected before fixation and processing
for immunofluorescence.
Antisera and Western Blotting. Rabbit anti-PB1 (V19), anti-
PB2 (2N580), anti-PA (V35), anti-NP (A2915), anti-M1, and anti-
NS1 sera have been described previously.38-40 Anti-NS2 and
anti-PB1-F2 sera were the kind gifts of Drs Agustin Portela and
Jonathan Yewdell respectively. Anti-RPA43 was a rhodamine
conjugated antibody raised in sheep. Mouse monoclonal anti-
hnRNP M (RPM), adenosine deaminase acting on RNA 1
(ADAR1), nucleolin, fibrillarin, hnRNP A1, alpha-tubulin, beta-
tubulin, GAPDH and nucleophosmin (NPM) were purchased
from Abcam. Secondary antibodies were purchased from
Molecular Probes, LiCor Biosciences, Sigma or DAKO. Cell
lysates were analyzed by SDS-PAGE and Western blotting
according to standard procedures. Blots were imaged by
fluorescence using IRDye 700/800 conjugated secondary an-
tibodies on a Licor Biosciences Odyssey near-infrared imaging
platform.
Confocal Microscopy. For confocal microscopy, cells were
fixed in 4% formaldehyde, permeabilised with 0.2% Triton X100
in phosphate buffered saline and probed with the desired
combinations of primary and secondary antibodies as previ-
ously described.34 Images (single optical sections) were cap-
tured sequentially on a Leica TCS-NT or DMI 4000 confocal
microscope and processed for daylight display using Adobe
Photoshop.
Growth of Cells for SILAC and Subcellular Fractionation.
293-T cells were maintained in stable isotope-labeled Dulbec-
co’s modified Eagle’s medium (Dundee Cell products) supple-
mented with 10% dialyzed fetal bovine serum (Dundee Cell
Products), penicillin/streptomycin and incubated at 37 °C in
the presence of 5% CO2. Cells were grown in stable isotope-
labeled growth media containing “light” (R0K0), “medium”
(R6K4) or “heavy” (R10K8) arginine and lysine for a period of
2 weeks prior to infection. Twenty-five million cells were seeded
into 500 cm2 dishes and grown for 24 h at which point cells
were infected with virus or mock-infected with allantoic fluid.
At 10 h postinfection, cells were harvested. (Note that both
viruses productively infect 293-T cells, under these conditions
of single cycle growth. PR8 strain replicates to around 1 × 107
PFU/mL while, as expected for a filamentous strain, Udorn
replicates slightly less to around 1 × 106 PFU/mL.) Subcellular
fractionation was carried out as described42 with the following
modifications: Incubation time in buffer A prior to dounce
homogenization was increased to 10 min, the number of
dounce homogenization strokes was decreased to 8, and the
number of sonication repeats increased to 8.
Gel Electrophoresis and In-Gel Digestion. Each sample was
reduced in SDS-PAGE loading buffer containing 10 mM DTT
and alkylated in 50 mM iodoacetamide prior to being boiled
and then separated by one-dimensional SDS-PAGE (4-12% Bis-
Tris Novex mini-gel, Invitrogen) and visualized by colloidal
Coomassie staining (Novex, Invitrogen). The entire protein gel
lane was excised and cut into 10 gel slices each. Gel slices were
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subjected to in-gel digestion with trypsin.41 The resulting tryptic
peptides were extracted by 1% formic acid, acetonitrile, lyoph-
ilized in a Speedvac (Helena Biosciences) and resuspended in
1% formic acid.
LC-MS/MS. LC-MS/MS was performed by Dundee Cell
Products Ltd. Trypsin digested peptides were separated using
an Ultimate U3000 (Dionex Corporation) nanoflow LC-system
consisting of a solvent degasser, micro and nanoflow pumps,
flow control module, UV detector and a thermostatted au-
tosampler. Ten microliters of sample (a total of 2 µg) was loaded
with a constant flow of 20 µL/min onto a PepMap C18 trap
column (0.3 mm id × 5 mm, Dionex Corporation). After trap
enrichment peptides were eluted off onto a PepMap C18 nano
column (75 mm × 15 cm, Dionex Corporation) with a linear
gradient of 5-35% solvent B (90% acetonitrile with 0.1% formic
acid) over 65 min with a constant flow of 300 nL/min. The
HPLC system was coupled to a LTQ Orbitrap XL (Thermo Fisher
Scientific Inc.) via a nano ES ion source (Proxeon Biosystems).
The spray voltage was set to 1.2 kV and the temperature of the
heated capillary was set to 200 °C. Full scan MS survey spectra
(m/z 335-1800) in profile mode were acquired in the Orbitrap
with a resolution of 60 000 after accumulation of 500 000 ions.
The five most intense peptide ions from the preview scan in
the Orbitrap were fragmented by collision-induced dissociation
(normalized collision energy 35%, activation Q 0.250 and
activation time 30 ms) in the LTQ after the accumulation of
10 000 ions. Maximal filling times were 1000 ms for the full
scans and 150 ms for the MS/MS scans. Precursor ion charge
state screening was enabled and all unassigned charge states
as well as singly charged species were rejected. The dynamic
exclusion list was restricted to a maximum of 500 entries with
a maximum retention period of 90 s and a relative mass
window of 10 ppm. The lock mass option was enabled for
survey scans to improve mass accuracy.42 The data were
acquired using Xcalibur software.
Quantification and Bioinformatics Analysis. Quantification
was performed with MaxQuant version 1.0.7.443 and was based
on two-dimensional centroid of the isotope clusters within each
SILAC pair. To minimize the effect of outliers, protein ratios
were calculated as the median of all SILAC pair ratios that
belonged to peptides contained in the protein. The percentage
variability of the quantitation was defined as the standard
deviation of the natural logarithm of all ratios used for
obtaining the protein ratio multiplied by a constant factor 100.
The generation of peak list, SILAC- and extracted ion current-
based quantitation, calculated posterior error probability, and
false discovery rate based on search engine results, peptide to
protein group assembly, and data filtration and presentation
was carried out using MaxQuant. The derived peak list was
searched with the Mascot search engine (version 2.1.04; Matrix
Science, London, U.K.) against a concatenated database com-
bining 80 412 proteins from International Protein Index (IPI)
human protein database version 3.6 (forward database), and
the reversed sequences of all proteins (reverse database).
Alternatively, database searches were done using Mascot
(Matrix Science) as the database search engine and the results
saved as a peptide summary before quantification using
MSQuant (http://msquant.sourceforge.net/). Parameters al-
lowed included up to three missed cleavages and two labeled
amino acids (arginine and lysine). Initial mass deviation of
precursor ion and fragment ions were up to 7 ppm and 0.5
Da, respectively. The minimum required peptide length was
set to 6 amino acids. To pass statistical evaluation, posterior
error probability (PEP) for peptide identification (MS/MS
spectra) should be below or equal to 0.1. The required false
positive rate (FPR) was set to 5% at the peptide level. False
positive rates or PEP for peptides were calculated by recording
the Mascot score and peptide sequence length-dependent
histograms of forward and reverse hits separately and then
using Bayes’ theorem in deriving the probability of a false
identification for a given top scoring peptide. At the protein
level, the false discovery rate (FDR) was calculated as the
product of the PEP of a protein’s peptides where only peptides
with distinct sequences were taken into account. Proteins were
quantified if at least one MaxQuant-quantifiable SILAC pair was
present. Identification was set to a false discovery rate of 1%
with a minimum of two quantifiable peptides. The set value
for FPR/PEP at the peptide level ensures that the worst
identified peptide has a probability of 0.05 of being false; and
proteins are sorted by the product of the false positive rates of
their peptides where only peptides with distinct sequences are
recognized. During the search, proteins are successively in-
cluded starting with the best-identified ones until a false
discovery rate of 1% is reached; an estimation based on the
fraction of reverse protein hits. Enzyme specificity was set to
trypsin allowing for cleavage of N-terminal to proline and
between aspartic acid and proline. Carbamidomethylation of
cysteine was searched as a fixed modification, whereas N-acetyl
protein and oxidation of methionine were searched as variable
modifications.
Data were analyzed through the use of Ingenuity Pathways
Analysis (Ingenuity Systems, www.ingenuity.com). Networks
and functional groupings were generated using data sets
containing gene identifiers and corresponding expression
values and uploaded into the application.
Results and Discussion
Proteomic Overview of the Effects of IAV Infection on the
Nucleolus. To provide a global view of the interaction of IAV
with the nucleolus quantitative proteomics using SILAC-
coupled to LC-MS/MS was employed. This analysis was
conducted once and a target list of cellular proteins whose
abundance changed in IAV-infected cells derived obtained. The
differential abundance of these proteins was then confirmed
using independent techniques including Western blot analysis
and confocal microscopy. In order to conduct the SILAC
analysis, 293-T cells were grown for six doubling times in either
light (R0K0), medium (R6K4) or heavy (R10K8) labeled media
before being infected with PR8, mock infected or infected with
Udorn virus respectively. PR8 is a human H1N1 isolate whose
passage history is now uncertain but is generally regarded as
heavily laboratory adapted, with the properties of high growth
yields in many culture systems as well as high pathogenicity
in mice.32,44 Udorn virus is a human H3N2 isolate that retains
the filamentous morphology associated with low passage
clinical isolates.31,34 Ten hours postinfection cells were enriched
into cytoplasmic, nucleoplasmic or nucleolar fractions as
described.45 To validate the fractionation process, the distribu-
tion of marker proteins for each cellular compartment was
examined by Western blotting, revealing acceptable levels of
purity (Figure 1). The subcellular localization of each of the
nontransmembrane IAV proteins was also examined (Figure
2A). Overall, similar levels of the viral proteins were seen in
samples from Udorn and PR8 infected cells, confirming suc-
cessful infection with both viruses. Most viral proteins were
detected to some extent in each of the three subcellular
Nucleolar Proteome in Influenza A Virus-Infected Cells research articles
Journal of Proteome Research • Vol. 9, No. 10, 2010 5337
fractions, with the possible exceptions of NEP, PB1-F2 and PB1-
N40. In the case of NEP and PB1-F2, cross-reactivity of the
antibodies with cellular components with similar electro-
phoretic mobilities found in nuclear and/or nucleolar fractions
as well as failure of the Udorn PB1-F2 to react with the
antiserum, prevented their unambiguous detection. The low
abundance PB1-N40 was mostly resident in the cytoplasm,
consistent with previous observations.5
However, the relative proportions of the viral proteins
present in each fraction varied, with the NP and NS1 polypep-
tides showing higher levels of nucleolar accumulation than the
M1 or polymerase subunits, again, consistent with previous
observations.14-17,26,28,46 Some differences were also observed
between the distributions of the PR8 and Udorn polypeptides:
the PR8 NS1 was notably more cytoplasmic than in Udorn
infection, consistent with the strain-dependent differences
noted previously for Udorn NS1 and the A/WSN/33 virus,26
which like PR8 NS1, lacks a second nuclear localization signal.
Smaller fluctuations in the degree of nucleolar association were
also seen for two NS1 polypeptides, as well as for M1, PB2 and
NEP. Next, the nucleolar fractions were analyzed by mass
spectrometry. Four viral proteins (HA, NP, M1 and NS1) were
identified by LC-MS/MS for the PR8 strain and six (PB2, HA,
NP, M1, NS1 and NS2) for the Udorn strain (Table 1).
This was broadly consistent with the outcome of the Western
blotting experiments, though the identification of the glyco-
protein HA as a nucleolar resident protein was unexpected and
may reflect contamination. Four-hundred thirty-eight cellular
proteins were identified and quantified in all three experimental
conditions. These proteins were then compared to the nucle-
olar proteome database and Uniprot annotation in order to
confirm classification as nucleolar and eliminate known con-
taminants such as voltage dependent anion-selective (VDAC)
proteins. This reduced the data set to 348 proteins identified
and quantified (Supplementary Table 1, Supporting Informa-
tion). The nucleolar proteome of 293-T cells contained proteins
associated with RNA post-transcriptional modification, gene
expression, DNA recombination and repair, cellular growth and
proliferation and protein synthesis and is similar to other
nucleolar proteomes that have been published for other cell
types45,47,48 (Figure 3).
For quantitative analysis of differences between paired
experimental samples, previous investigations using SILAC and
LC-MS/MS have applied ratio cutoffs ranging from near 1.3
to 2.0 fold.49 We chose a 2.0-fold cut off as a basis for
investigating potential significant changes between data sets
through Ingenuity Pathway Analysis and to provide a basis for
comparing the current data set to previous studies.21,45,50 Even
by this relatively strict criterion, the nucleolar abundance of
several cellular proteins were significantly altered in cells
infected with both strains of IAV (Udorn strain, Table 2; PR8
strain, Table 3).
However, clear differences were seen in the changes to the
nucleolar proteome induced by the two viruses. The majority
of the greater than 2-fold changes in abundance resulting from
Udorn infection involved loss of proteins from the nucleolus
(21 polypeptides, versus one showing increased nucleolar
residence). Inspection of the proteins depleted from the
nucleolus revealed some notable groupings. The largest set (5
members; Table 2) were all components of RNase P. The three
Figure 1. Western blot analysis of the distribution of marker
proteins for cytoplasmic (Cyt) (GAPDH, alpha-tubulin and beta-
tubulin), nuclear (Nuc) (Lamin B and hnRNP A1) and nucleolar
extracts (No) (nucleolin and fibrillarin) from mock or virus
infected cells. *Indicates the expected position of full-length
nucleolin, the faster migrating species are likely to be autocata-
lytic breakdown products.69
Figure 2. Western blot analysis of the distribution of (A) non-
transmembrane IAV PR8 (PR8) and Udorn (Ud) proteins and (B)
selected cellular nucleolar proteins identified in the LC-MS/MS
analysis between cytoplasmic (Cyt), nuclear (Nu) and nucleolar
(No) fractions. The PB1-F2 and NEP polypeptides are highlighted
with asterisks to distinguish them from cross-reactive cellular
polypepties with similar electrophoretic mobilities. Note also that
the NS1 and NEP proteins of PR8 and Udorn viruses display
slightly different electrophoretic mobility. The apparent discrep-
ancy in migration between the PR8 and Udorn PB1 polypeptides
in the nucleolar fraction was not seen in replicate gels and is
most likely an artifact.
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major components of nuclear paraspeckles (Table 2) also
showed significant reductions in nucleolar residence, as did
three subunits of the MLL1 histone H3 methyltransferase
complex and two subunits of RNA polymerase I. Interestingly,
the para-speckle protein SFPQ has been previously shown to
interact with the IAV polymerase,51 while the heat shock
proteins HSPA8 and the WD repeat protein, WDR18, were
identified as important for IAV replication in RNAi screens for
essential host factors.52-54 In contrast, PR8 infection did not
result in major loss of any detected protein (using the 2-fold
criterion), but instead caused the increased nucleolar associa-
tion of 3 cellular proteins (Table 3). Two of these proteins were
in common with the Udorn data set: nucleolar resident ADAR1
increased nearly 3-fold after infection with both viruses, but
while the Lupus La autoantigen was depleted from the nucleo-
lus after Udorn infection, it increased in PR8-infected cells. The
third protein showing a 2-fold increased nucleolar abundance
in PR8 infected cells was a polypeptide similar to Elongation
factor gamma (Table 3). This protein also increased in the
nucleolus after Udorn infection, but although it showed the
second highest enrichment after ADAR1, this was only 1.6-fold
(Supplementary Table 1, Supporting Information). Other simi-
larities between the effects of Udorn and PR8 infection were
evident if lower stringency criteria were used to draw a cutoff:
WDR18 was the fifth most depleted protein identified from PR8
nucleoli (ratio of -1.4), while the POP5 subunit of RNaseP
showed a ratio of -1.3 (Supplementary Table 1, Supporting
Information). However, the most reduced proteins (ratios of
1.4 to -1.6) were hnRNP proteins and splicing factors (Supple-
mentary Table 1, Supporting Information). This included a
subunit of splicing factor 3B (SF3B; ratio of -1.5) previously
identified as important for IAV replication.54,55
Validation of the SILAC and LC-MS/MS Data. Next, we
validated the outcome of the SILAC and LC-MS/MS data by
examining the response of selected cellular proteins to viral
infection by Western blotting and/or confocal microscopy,
testing proteins that showed an increased, no change or
decreased abundance in the nucleolus in response to IAV
infection. One protein whose nucleolar abundance was in-
creased after infection with both viruses was ADAR1 protein
(Tables 2 and 3). ADAR1 is an interferon-inducible RNA-editing
protein with a potential role in innate antiviral immunity,
Table 1. Influenza A Virus Proteins Identified from Nucleolar Fractionsa
name gene identifier (GI) number peptides % sequence coverage PEP protein function
A/Puerto Rico/8/1934 Strain
HA gi126599270 3 5.3 5.2 × 10-11 Surface glycoprotein, interacts with receptor.
NP gi126599284 26 58.6 2.4 × 10-205 Encapsidate the virus genome.
M1 gi126599292 14 75.4 1.7 × 10-101 Role in virus entry and assembly.
NS1 gi126599211 13 64.3 6.5 × 10-156 Inhibits post-transcriptional processing of cellular
pre-mRNA.
A/Udorn/307/1972
PB2 gi18615852 6 10.8 8.4 × 10-38 Viral transcription initiation and cap-snatching.
HA gi18615858 6 11.5 6.5 × 10-42 Surface glycoprotein, interacts with receptor.
NP gi18615860 24 49 2.2 × 10-141 Encapsidate the virus genome.
M1 gi18615864 13 67.1 4.3 × 10-83 Role in virus entry and assembly.
NS1 gi18615868 21 84.8 6.8 × 10-296 Inhibits post-transcriptional processing of cellular
pre-mRNA.
NS2 gi18615870 13 28.1 4.5 × 10-10 Nuclear export of encapsidated genomic RNAs.
a Detailed are the viral protein name, gene identifier number, number of peptides for identification, the sequence coverage on the viral protein this
represents and the posterior error probability (PEP) score, which is a probability that an individual match is a chance event.
Figure 3. Ingenuity Pathway Analysis of the nucleolar proteome in 293-T cells showing the relative proportion of each functional category
of proteins.
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Table 2. Cellular Proteins Showing g 2-Fold Changes in Abundance Following Infection with IAV (Strain Udorn)a
name IPI no. complex ratio pept %SC PEP protein function(s)
Proteins showing increased abundance
ADAR1 IPI00394668 PSE 2.8 19 18.4 3.7 × 10-147 RNA editing, converts
adenosines to inosines. May
be responsible for
hypermutation of RNA viruses.
Proteins showing decreased abundance
PSPC1 IPI00103525 PSE -2.1 9 14.5 9.1 × 10-10 Regulates gene transcription
with NONO and SFPQ. Binds
to poly(A), poly(G) and
poly(U) in RNA.
SFPQ IPI00010740 PSE -2.5 23 34.8 5.4 × 10-202 DNA and RNA binding protein
required in early spliceosome
formation.
NONO IPI00304596 PSE -2.5 34 55.8 3.3 × 10-198 DNA and RNA binding protein
involved in pre-mRNA
splicing. Together with NONO
may be involved in retention
of defective RNAs.
PELP1 IPI00006702 MLL1 -2.0 7 8.6 9.0 × 10-16 Role in E2-mediated cell cycle
progression by interacting
with RB1.
TEX10 IPI00549664 MLL1 -2.1 3 4.8 2.1 × 10-14 Unknown.
LAS1L IPI00641990 MLL1 -2.2 8 14.9 1.1 × 10-83 Unknown.
Ribonuclease P IPI00478229 RNaseP -2.0 4 18 1.5 × 10-47 Generates mature tRNAs.
POP1 IPI00293331 RNaseP -2.1 2 2.8 0.001 Removes 5′-extra nucleotides
from tRNA precursor.
POP5 IPI00107563 RNaseP -2.0 3 19 0.0001 Removes 5′-extra nucleotides
from tRNA precursor.
POP7 IPI00027142 RNaseP -2.1 2 24.3 1.8 × 10-24 Removes 5′-extra nucleotides
from tRNA precursor.
RPP14 IPI00215966 RNaseP -2.1 2 27.4 7.1 × 10-19 Removes 5′-extra nucleotides
from tRNA precursor.
POLR1B IPI00418797 RNAPI -2.0 4 4.9 5.1 × 10-24 Core component and
contributes to catalytic
activity.
RPA43 IPI00005477 RNAPI -2.1 2 8.3 2.6 × 10-07 Recruitment of Pol I to rDNA
promoters.
HSPA8 IPI00003865 -2.0 5 9.8 1.6 × 10-16 ATP binding belongs to HSP70
family.
RPL24 IPI00873403 -2.0 2 12.7 8.9 × 10-10 Ribosomal protein.
C16orf88 IPI00554560 -2.0 3 8.5 2.3 × 10-08 Unknown.
WDR18 IPI00032533 -2.1 7 17.4 2.2 × 10-35 Unknown.
C6orf153 IPI00106638 -2.2 4 18.5 1.9 × 10-24 Ribosome biogenesis and rRNA
processing.
Lupus La IPI00009032 -2.3 2 7.1 9.8 × 10-11 Transcription of RNA pol III.
NOL9 IPI00002902 -2.5 7 14.1 1.2 × 10-28 Unknown.
UTP23 IPI00031612 -2.8 2 9.2 0.002 Ribosome biogenesis and rRNA
processing.
a Shown is the protein name, International Protein Index number, (for selected cases) the functional complex/group it falls in, protein ratio in infected
versus mock infected nucleoli, number of peptides used to identify the protein (Pept), the sequence coverage on the protein this represents (%SC) and the
PEP score. Abreviations for functional complexes are: PS/E, paraspeckles/A-I RNA editing; MLL1, Components of the MLL1 histone H3 methyltransferase
complex; RNAseP, RNAse P components; RNAPI, RNA polymerase I.
Table 3. Cellular Proteins Showing g 2-Fold Changes in Abundance Following Infection with Influenza Virus (Strain PR8)a
name IPI no. complex ratio pept %SC PEP protein function(s)
ADAR1 IPI00394668 PS/E 2.9 19 18.4 3.7 × 10-147 RNA editing, converts
adenosines to inosines. May
be responsible for
hypermutation of RNA viruses.
Lupus La IPI00009032 3.3 2 7.1 9.8 × 10-11 Transcription of RNA pol III.
Similar to EF1 gamma IPI00000875 2.0 5 12.1 1.8 × 10-37 Translation elongation.
a Shown is the protein name, International Protein Index number, (for selected cases) the functional complex/group it falls in, protein ratio in infected
versus mock infected nucleoli, number of peptides used to identify the protein, the sequence coverage on the protein this represents and the PEP score.
Abbreviations for functional complexes are: PS/E, paraspeckles/A-I RNA editing.
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including against IAV, and which has also been reported to
interact with NS1 protein.56-58 Western blotting confirmed that
increased amounts of both long (150 kDa) and short (110 kDa)
forms of ADAR1 were seen in the nucleolar fraction from IAV
infected cells (Figure 2B). When mock-infected 293-T cells were
examined by confocal microscopy, ADAR1 was predominately
nucleoplasmic, whereas in the majority of IAV infected cells
(as delineated by positive staining for viral NP) there was a
marked increase in fluorescence in the nucleolus (Figure 4),
verifying the proteomic analysis.
Genetic studies in mice infected with IAV indicated that
ADAR1 can edit at least one of the viral mRNAs and may be
part of an antiviral response.57 It is therefore tempting to
speculate that sequestration of ADAR1 to the nucleolus in
influenza virus infected cells is a mechanism to mitigate its
antiviral activity.
As examples of proteins whose abundance did not change
dramatically in the LC-MS/MS analysis we analyzed the
subcellular localization of heterogeneous nuclear ribonucle-
oprotein M (RPM or hnRNP M) and NPM, both of which have
been defined as interaction partners of the viral polymerase
and/or RNP.25,51 The fold changes in nucleolar abundance for
RPM were -1.5 for both viruses and for NPM, 1.09 (PR8) and
-1.5 (Udorn). Confocal microscopy of uninfected 293-T cells
showed that RPM mostly localized to the nucleoplasm with a
slight preference for the nuclear periphery (Figure 5). This
pattern was unchanged after infection with PR8 virus, although
reasonable colocalization was seen between NP and RPM
(Figure 5). Here, the low intensity staining of the nucleolus in
uninfected cells hindered identification of whether infection
caused a further reduction.
Next, focusing on NPM, we investigated a potential discrep-
ancy between our results and a previous study examining the
interaction of IAV with this protein. Mayer and colleagues
showed that IAV infection induced the redistribution of re-
combinant Flag-tagged NPM out of the nucleolus of MDCK
cells at late times postinfection (6-8 h p.i.), where it partially
colocalized with nuclear NP.25 In contrast, our SILAC LC-MS/
MS analysis showed little effect on the bulk localization of NPM
in the nucleolus of infected 293-T cells. First, we examined NPM
distribution in the 293-T cell fractions by Western blot, which,
consistent with the proteomics analysis, showed no change in
nucleolar content after infection (Figure 2B). We therefore
asked if we could reproduce NPM relocalization effects in
infected cells by immunofluorescence, as well as testing if cell
type influenced the outcome, by analyzing endogenous NPM
localization in MDCK and 293-T cells infected or mock infected
with PR8 virus. Although NPM has the ability to shuttle to the
cytoplasm59 it localized predominantly to the nucleolus in
uninfected MDCK cells (Figure 6A), as was previously observed
for Flag-NPM.25 Occasionally, strong cytoplasmic NPM staining
was detected in dividing cells as judged by DAPI staining (data
not shown). NPM also localized to the nucleolus of uninfected
293-T cells but this was less pronounced than in MDCK cells
Figure 4. Indirect immunofluorescence confocal microscopy
analysis of the subcellular localization of ADAR1 in mock-infected
and infected (PR8 and Udorn) cells at 12 h p.i. IAV NP is shown
in red, ADAR1 in green, the nucleus is stained with DAPI (blue)
and a merge image is presented. Note that NP localizes to the
apical plasma membrane late in infection and is therefore only
seen at the periphery of cell clumps in the optical sections shown.
Figure 5. Indirect immunofluorescence confocal microscopy
analysis of the subcellular localization of RPM in mock-infected
and PR8 infected cells at 8 h p.i. IAV NP is shown in green, RPM
in red, and a merge image is presented.
Figure 6. Indirect immunofluorescence confocal microscopy
analysis of the distribution of NPM (red) in mock and PR8-infected
(green) (A) MDCK and (B) 293-T cells at 11 h p.i. Arrows highlight
examples of cells where nucleolar NPM staining is lost.
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and higher intensity staining of the nucleoplasm was detected
(Figure 6B). In both cell types no change in NPM staining was
detected at early time-points of infection (data not shown).
However, at 11 h p.i. nucleolar NPM localization was distinctly
diminished in a subset of infected cells (indicated with white
arrows, Figure 6A and B), with the effect being more pro-
nounced in MDCK cells. A similar outcome was obtained with
Udorn virus (data not shown).
Thus, we observed similar effects of infection on NPM
localization to those described by Mayer et al. (2007), albeit
less marked and only occurring in a fraction of infected cells.
Some of these discrepancies might be accounted for by virus
strain (A/WSN/33 vs PR8) or by the fact that Mayer and
colleagues examined recombinant, tagged NPM and not en-
dogenous protein.25 However, we think the fact that we only
saw relocalization of NPM in some and not all infected cells,
together with the less pronounced nucleolar localization of
NPM in 293-T cells accounts for the failure to detect a
significant reduction in the NPM nucleolar content by SILAC
analysis. We also note that a recent study also found that IAV
infection only resulted in NPM relocalization in a subset of
infected duck embryo fibroblasts.28
LC-MS/MS analysis indicated that several proteins associ-
ated with ribonuclease P (RNaseP) were decreased in abun-
dance in the nucleolus of Udorn infected cells, including POP1
and POP5. RNaseP is a large ribonucleoprotein complex that
generates mature tRNA molecules by cleaving the 5′ leader
sequence of precursor tRNAs. However, there is also evidence
that nuclear RNaseP is involved in the transcription of tRNA
genes and other small noncoding RNAs by RNA polymerase
III as well as rRNA by RNA polymerase I.60,61 To examine the
response of RNaseP polypeptides to IAV infection by micros-
copy, cells were transfected with a plasmid encoding a tagged
form of POP1 then infected (or mock infected) with virus. In
mock-infected cells, POP1 predominantly localized to the
nucleolus, with some staining of the nucleoplasm, whereas in
Udorn infected cells, this pattern was reversed, with often
weaker signals from nucleolar regions than the nucleoplasm
(Figure 7). PR8 infection also provoked some redistribution of
POP1, although to a less marked extent than Udorn infection.
Again, these data are consistent with the mass spectrometry
findings.
As a final test of the accuracy of the proteomic analysis, we
examined the subcellular localization of the RPA43 subunit of
RNA polymerase I after infection, as the SILAC analysis showed
substantial reductions in its nucleolar residence in Udorn but
not PR8 infected cells (fold changes of -2.1 versus 1.1 respec-
tively; Table 2). Twelve h p.i. infected or mock infected cells
were fixed and stained for RPA43 and NP. In uninfected cells,
RPA43 displayed the expected staining pattern of prominent
nucleolar foci, although it is uncertain whether the cytoplasmic
staining for RPA43 is specific (Figure 8). This pattern largely
persisted in PR8 infected cells although some cells showed
reduced numbers and/or fainter nucleolar foci. In contrast,
near complete disruption of the normal RPA43 localization was
seen in Udorn infected cells, with the staining revealing very
few bright foci that moreover were not universally associated
with the nucleolar regions.
Overall we have tested the SILAC/mass spectrometry data
by Western blotting and/or microscopy for several cellular
proteins, finding good congruence between the experimental
methods. This observation is in keeping with our previous
analyses using SILAC coupled to LC-MS/MS and validation
of data sets.21,45,50,62 Therefore, we conclude that the SILAC
database is likely to be a fair and accurate reflection of the IAV-
induced changes to the nucleolar proteome. As a future analysis
it would be interesting to test if the differences between the
two strains correlate with the established differences between
nuclear/nucleolar targeting and/or IFN-evasion activities of PR8
and H3N2 NS1 proteins.
Comparison of the Nucleolar Proteome Changes in Influ-
enza A Virus-Infected Cells with Those of Other Viruses. The
nucleolar proteome in the context of infection has been
characterized for two other very different viruses; adenovirus21
and the coronavirus infectious bronchitis virus (IBV).45 Aden-
oviruses are double stranded DNA viruses that replicate in the
nucleus of infected cells, whereas coronaviruses have positive
stranded RNA genomes that replicate in the cytoplasm. Nev-
ertheless, proteins from both viruses have been shown to
Figure 7. Indirect immunofluorescence confocal microscopy
analysis of the subcellular localization of POP1 in mock-infected
and infected (PR8 and Udorn) cells at 6 h p.i. IAV NP is shown in
red, POP1 in green, the nucleus is stained with DAPI (blue) and
a merge image is presented.
Figure 8. Indirect immunofluorescence confocal microscopy
analysis of the subcellular localization of RPA43 in mock-infected
and infected (PR8 and Udorn) cells at 12 h p.i. IAV NP is shown
in green, RPA43 in red, the nucleus is stained with DAPI (blue)
and a merge image is presented.
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localize to the nucleolus in infected cells.63-68 Proteomic
analysis revealed that similar to this study, global nucleolar
proteome changes did not occur in adenovirus and coronavirus
infected cells, and only a subset of nucleolar proteins changed
in abundance.21,45 We therefore compared the fold changes
found in the set of proteins that were identified and quantified
in each nucleolar proteome experiment. To this end, the
proteins in common to the various experiments were sorted
according to the fold change in Udorn infected cells and plotted
side by side.
In general the changes seen in Udorn and adenovirus
infections were somewhat more similar than between PR8 and
the other two data sets (Figure 9A). However, only a very small
number of proteins showed a significant change during viral
infection (as defined by a 2-fold alteration in abundance) in
the nucleolus of either adenovirus or IAV infected cells. That
adenovirus and Udorn seem more similar may possibly reflect
the observation that both cause symptomatic respiratory
infections in humans, whereas PR8 does not. Further investiga-
tion will determine if this really is the case. A similar compari-
son of some 230 nucleolar proteins between IBV and both IAV
strains revealed no major similarities (Figure 9B).
However, these data show that viral infection causes a
significant change in only a small subset of nucleolar proteins.
In addition, these viruses apparently disturb different aspects
of the nucleolar proteome reflecting their different replication
strategies and host pathogenicity. These two observations re-
enforce a highly significant point: viral effects on the nucleolus
are targeted rather than a result of collateral damage arising
from the cell eventually succumbing to infection. The data
presented here suggest that at least one strain of IAV targets
specific nucleolar-related pathways; further work is ongoing to
test the functional significance of this.
Acknowledgment. E.E. is supported by the award of a
BBSRC doctoral training grant to the Astbury Centre for
Structural Molecular Biology. JAH is a Leverhulme Trust
Research Fellow. D.A.M. is supported by the Wellcome Trust
grant number 083604. P.D. and H.M.W. are supported by
MRC grant number G0700815 and EML was supported by
the Loke Van Tho studentship. Dr. Paul Ajuh and team at
Dundee Cell Products Ltd is kindly thanked for their input
and help with interpretation of protein quantification.
Supporting Information Available: Supplementary
table. This material is available free of charge via the Internet
at http://pubs.acs.org.
References
(1) Webby, R. J.; Webster, R. G. Are we ready for pandemic influenza.
Science 2003, 302 (5650), 1519–1522.
(2) Webster, R. G.; Bean, W. J.; Gorman, O. T.; Chambers, T. M.;
Kawaoka, Y. Evolution and ecology of influenza A viruses. Micro-
biol. Rev. 1992, 56 (1), 152–179.
(3) Morens, D. M.; Taubenberger, J. K.; Fauci, A. S. The persistent
legacy of the 1918 influenza virus. N. Engl. J. Med. 2009, 361 (3),
225–229.
(4) Chen, W.; Calvo, P. A.; Malide, D.; Gibbs, J.; Schubert, U.; Bacik,
I.; Basta, S.; O’Neill, R.; Schickli, J.; Palese, P.; Henklein, P.; Bennink,
J. R.; Yewdell, J. W. A novel influenza A virus mitochondrial protein
that induces cell death. Nat. Med. 2001, 7 (12), 1306–1312.
(5) Wise, H. M.; Foeglein, A.; Sun, J.; Dalton, R. M.; Patel, S.; Howard,
W.; Anderson, E. C.; Barclay, W. S.; Digard, P. A complicated
message: Identification of a novel PB1-related protein translated
from influenza A virus segment 2 mRNA. J. Virol. 2009, 83 (16),
8021–8031.
(6) Portela, A.; Digard, P. The influenza virus nucleoprotein: a mul-
tifunctional RNA-binding protein pivotal to virus replication.
J. Gen. Virol. 2002, 83 (Pt 4), 723–734.
(7) Nayak, D. P.; Balogun, R. A.; Yamada, H.; Zhou, Z. H.; Barman, S.
Influenza virus morphogenesis and budding. Virus Res. 2009, 143
(2), 147–161.
(8) Hale, B. G.; Randall, R. E.; Ortin, J.; Jackson, D. The multifunctional
NS1 protein of influenza A viruses. J. Gen. Virol. 2008, 89 (Pt 10),
2359–2376.
(9) Neumann, G.; Brownlee, G. G.; Fodor, E.; Kawaoka, Y. Orthomyxo-
virus replication, transcription, and polyadenylation. Curr. Top.
Microbiol. Immunol. 2004, 283, 121–143.
(10) Amorim, M. J.; Digard, P. Influenza A virus and the cell nucleus.
Vaccine 2006, 24 (44-46), 6651–6655.
(11) Josset, L.; Frobert, E.; Rosa-Calatrava, M. Influenza A replication
and host nuclear compartments: many changes and many ques-
tions. J. Clin. Virol. 2008, 43 (4), 381–390.
(12) Engelhardt, O. G.; Fodor, E. Functional association between viral
and cellular transcription during influenza virus infection. Rev.
Med. Virol. 2006, 16 (5), 329–345.
(13) Hiscox, J. A. RNA viruses: hijacking the dynamic nucleolus. Nat.
Rev. Microbiol. 2007, 5, 119–127.
(14) Dimmock, N. J. New virus-specific antigens in cells infected with
influenza virus. Virology 1969, 39 (2), 224–234.
(15) Ter Meulen, V.; Love, R. Virological, immunochemical, and cy-
tochemical studies of four HeLa cell lines infected with two strains
of influenza virus. J. Virol. 1967, 1 (3), 626–639.
(16) Taylor, J. M.; Hampson, A. W.; Layton, J. E.; White, D. O. The
polypeptides of influenza virus. IV. An analysis of nuclear ac-
cumulation. Virology 1970, 42 (3), 744–752.
(17) Krug, R. M.; Etkind, P. R. Cytoplasmic and nuclear virus-specific
proteins in influenza virus-infected MDCK cells. Virology 1973,
56 (1), 334–348.
(18) Murayama, R.; Harada, Y.; Shibata, T.; Kuroda, K.; Hayakawa, S.;
Shimizu, K.; Tanaka, T. Influenza A virus non-structural protein 1
(NS1) interacts with cellular multifunctional protein nucleolin
during infection. Biochem. Biophys. Res. Commun. 2007, 362 (4),
880–885.
(19) Emmott, E.; Hiscox, J. A. Nucleolar targetting: the hub of the
matter. EMBO Rep. 2009, 10, 231–238.
(20) Dove, B. K.; You, J. H.; Reed, M. L.; Emmett, S. R.; Brooks, G.;
Hiscox, J. A. Changes in nucleolar morphology and proteins during
infection with the coronavirus infectious bronchitis virus. Cell.
Microbiol. 2006, 8 (7), 1147–1157.
Figure 9. Fold changes (relative to uninfected cells) of (A) 199
nucleolar proteins after infection with adenovirus (blue), PR8
(green) and Udorn (red) viruses and 230 nucleolar proteins after
infection with IBV (blue), PR8 (green) and Udorn (red) viruses.
In this plot, a change of +1/-1 indicates a 2-fold increase or
decrease in that protein’s abundance in the nucleoli of an infected
cell and between 0 and 1 represents no significant change in
abundance between infected and uninfected cells. Thus, out-
wardly while opposite changes appear between the PR8 strain
and adenovirus, only a few of these are greater than 2-fold.
Nucleolar Proteome in Influenza A Virus-Infected Cells research articles
Journal of Proteome Research • Vol. 9, No. 10, 2010 5343
(21) Lam, Y. W.; Evans, V. C.; Heesom, K. J.; Lamond, A. I.; Matthews,
D. A. Proteomics analysis of the nucleolus in adenovirus-infected
cells. Mol. Cell. Proteomics 2009, 9 (1), 117–130.
(22) Hiscox, J. A.; Whitehouse, A.; Matthews, D. A. Nucleolar proteomics
and viral infection. Proteomics 2010, DOI: 10.1002/pmic.201000251.
(23) Fuhrman, L. E.; Goel, A. K.; Smith, J.; Shianna, K. V.; Aballay, A.
Nucleolar proteins suppress Caenorhabditis elegans innate im-
munity by inhibiting p53/CEP-1. PLoS Genet. 2009, 5 (9), e1000657.
(24) Compans, R. W.; Dimmock, N. J. An electron microscopic study
of single-cycle infection of chick embryo fibroblasts by influenza
virus. Virology 1969, 39 (3), 499–515.
(25) Mayer, D.; Molawi, K.; Martinez-Sobrido, L.; Ghanem, A.; Thomas,
S.; Baginsky, S.; Grossmann, J.; Garcia-Sastre, A.; Schwemmle, M.
Identification of cellular interaction partners of the influenza virus
ribonucleoprotein complex and polymerase complex using pro-
teomic-based approaches. J. Proteome Res. 2007, 6 (2), 672–682.
(26) Melen, K.; Kinnunen, L.; Fagerlund, R.; Ikonen, N.; Twu, K. Y.; Krug,
R. M.; Julkunen, I. Nuclear and nucleolar targeting of influenza A
virus NS1 protein: striking differences between different virus
subtypes. J. Virol. 2007, 81 (11), 5995–6006.
(27) Young, J. F.; Desselberger, U.; Palese, P.; Ferguson, B.; Shatzman,
A. R.; Rosenberg, M. Efficient expression of influenza virus NS1
nonstructural proteins in Escherichia coli. Proc. Natl. Acad. Sci.
U.S.A. 1983, 80 (19), 6105–6109.
(28) Volmer, R.; Mazel-Sanchez, B.; Volmer, C.; Soubies, S. M.; Guerin,
J. L. Nucleolar localization of influenza A NS1: striking differences
between mammalian and avian cells. Virol. J. 2010, 7, 63.
(29) Sheval, E. V.; Polzikov, M. A.; Olson, M. O.; Zatsepina, O. V. A higher
concentration of an antigen within the nucleolus may prevent its
proper recognition by specific antibodies. Eur. J. Histochem. 2005,
49 (2), 117–124.
(30) DuBridge, R. B.; Tang, P.; Hsia, H. C.; Leong, P. M.; Miller, J. H.;
Calos, M. P. Analysis of mutation in human cells by using an
Epstein-Barr virus shuttle system. Mol. Cell. Biol. 1987, 7 (1), 379–
387.
(31) Carrasco, M.; Amorim, M. J.; Digard, P. Lipid raft-dependent
targeting of the influenza A virus nucleoprotein to the apical
plasma membrane. Traffic 2004, 5 (12), 979–992.
(32) de Wit, E.; Spronken, M. I.; Bestebroer, T. M.; Rimmelzwaan, G. F.;
Osterhaus, A. D.; Fouchier, R. A. Efficient generation and growth
of influenza virus A/PR/8/34 from eight cDNA fragments. Virus
Res. 2004, 103 (1-2), 155–161.
(33) Roberts, P. C.; Compans, R. W. Host cell dependence of viral
morphology. Proc. Natl. Acad. Sci. U.S.A. 1998, 95 (10), 5746–5751.
(34) Simpson-Holley, M.; Ellis, D.; Fisher, D.; Elton, D.; McCauley, J.;
Digard, P. A functional link between the actin cytoskeleton and
lipid rafts during budding of filamentous influenza virions. Virology
2002, 301 (2), 212–225.
(35) Bruce, E. A.; Medcalf, L.; Crump, C. M.; Noton, S. L.; Stuart, A. D.;
Wise, H. M.; Elton, D.; Bowers, K.; Digard, P. Budding of filamen-
tous and non-filamentous influenza A virus occurs via a VPS4 and
VPS28-independent pathway. Virology 2009, 390 (2), 268–278.
(36) Hutchinson, E. C.; Curran, M. D.; Read, E. K.; Gog, J. R.; Digard,
P. Mutational analysis of cis-acting RNA signals in segment 7 of
influenza A virus. J. Virol. 2008, 82 (23), 11869–11879.
(37) Welting, T. J.; Kikkert, B. J.; van Venrooij, W. J.; Pruijn, G. J.
Differential association of protein subunits with the human RNase
MRP and RNase P complexes. RNA 2006, 12 (7), 1373–1382.
(38) Digard, P.; Blok, V. C.; Inglis, S. C. Complex formation between
influenza virus polymerase proteins expressed in Xenopus oocytes.
Virology 1989, 171 (1), 162–169.
(39) Elton, D.; Amorim, M. J.; Medcalf, L.; Digard, P. ‘Genome gating’;
polarized intranuclear trafficking of influenza virus RNPs. Biol. Lett.
2005, 1 (2), 113–117.
(40) Amorim, M. J.; Read, E. K.; Dalton, R. M.; Medcalf, L.; Digard, P.
Nuclear export of influenza A virus mRNAs requires ongoing RNA
polymerase II activity. Traffic 2007, 8 (1), 1–11.
(41) Shevchenko, A.; Wilm, M.; Vorm, O.; Mann, M. Mass spectrometric
sequencing of proteins silver-stained polyacrylamide gels. Anal.
Chem. 1996, 68 (5), 850–858.
(42) Olsen, J. V.; de Godoy, L. M.; Li, G.; Macek, B.; Mortensen, P.; Pesch,
R.; Makarov, A.; Lange, O.; Horning, S.; Mann, M. Parts per million
mass accuracy on an Orbitrap mass spectrometer via lock mass
injection into a C-trap. Mol. Cell. Proteomics 2005, 4 (12), 2010–
2021.
(43) Cox, J.; Mann, M. MaxQuant enables high peptide identification
rates, individualized p.p.b.-range mass accuracies and proteome-
wide protein quantification. Nat. Biotechnol. 2008, 26 (12), 1367–
1372.
(44) Francis, T., Jr. Transmission of Influenza by a Filterable Virus.
Science 1934, 80 (2081), 457–459.
(45) Emmott, E.; Rodgers, M.; Macdonald, M.; McCrory, S.; Ajuh, P.;
Hiscox, J. A. Quantitative proteomics using stable isotope labeling
with amino acids in cell culture (SILAC) reveals changes in the
cytoplasmic, nuclear and nucleolar proteomes in Vero cells
infected with the coronavirus infectious bronchitis virus.Mol. Cell.
Proteomics 2010, DOI: 10.1074/mcp.M900345-MCP200.
(46) Ozawa, M.; Fujii, K.; Muramoto, Y.; Yamada, S.; Yamayoshi, S.;
Takada, A.; Goto, H.; Horimoto, T.; Kawaoka, Y. Contributions of
two nuclear localization signals of influenza A virus nucleoprotein
to viral replication. J. Virol. 2007, 81 (1), 30–41.
(47) Pendle, A. F.; Clark, G. P.; Boon, R.; Lewandowska, D.; Lam, Y. W.;
Andersen, J.; Mann, M.; Lamond, A. I.; Brown, J. W.; Shaw, P. J.
Proteomic analysis of the Arabidopsis nucleolus suggests novel
nucleolar functions. Mol. Biol. Cell 2005, 16 (1), 260–269.
(48) Leung, A. K.; Andersen, J. S.; Mann, M.; Lamond, A. I. Bioinformatic
analysis of the nucleolus. Biochem. J. 2003, 376, 553–569.
(49) Mann, M. Functional and quantitative proteomics using SILAC.
Nat. Rev. Mol. Cell. Biol. 2006, 7 (12), 952–958.
(50) Emmott, E.; Smith, C.; Emmett, S. R.; Dove, B. K.; Hiscox, J. A.
Elucidation of the avian nucleolar proteome by quantitative
proteomics using stable isotope labeling with amino acids in cell
culture (SILAC) and alteration in the coronavirus infectious
bronchitis virus infected cells. Proteomics 2010, DOI: 10.1002/pmic.
201000139.
(51) Jorba, N.; Juarez, S.; Torreira, E.; Gastaminza, P.; Zamarreno, N.;
Albar, J. P.; Ortin, J. Analysis of the interaction of influenza virus
polymerase complex with human cell factors. Proteomics 2008, 8
(10), 2077–2088.
(52) Hao, L.; Sakurai, A.; Watanabe, T.; Sorensen, E.; Nidom, C. A.;
Newton, M. A.; Ahlquist, P.; Kawaoka, Y. Drosophila RNAi screen
identifies host genes important for influenza virus replication.
Nature 2008, 454 (7206), 890–893.
(53) Konig, R.; Stertz, S.; Zhou, Y.; Inoue, A.; Hoffmann, H. H.;
Bhattacharyya, S.; Alamares, J. G.; Tscherne, D. M.; Ortigoza, M. B.;
Liang, Y.; Gao, Q.; Andrews, S. E.; Bandyopadhyay, S.; De Jesus,
P.; Tu, B. P.; Pache, L.; Shih, C.; Orth, A.; Bonamy, G.; Miraglia, L.;
Ideker, T.; Garcia-Sastre, A.; Young, J. A.; Palese, P.; Shaw, M. L.;
Chanda, S. K. Human host factors required for influenza virus
replication. Nature 2010, 463 (7282), 813–817.
(54) Brass, A. L.; Huang, I. C.; Benita, Y.; John, S. P.; Krishnan, M. N.;
Feeley, E. M.; Ryan, B. J.; Weyer, J. L.; van der Weyden, L.; Fikrig,
E.; Adams, D. J.; Xavier, R. J.; Farzan, M.; Elledge, S. J. The IFITM
proteins mediate cellular resistance to influenza A H1N1 virus,
West Nile virus, and dengue virus. Cell 2009, 139 (7), 1243–1254.
(55) Karlas, A.; Machuy, N.; Shin, Y.; Pleissner, K. P.; Artarini, A.; Heuer,
D.; Becker, D.; Khalil, H.; Ogilvie, L. A.; Hess, S.; Maurer, A. P.;
Muller, E.; Wolff, T.; Rudel, T.; Meyer, T. F. Genome-wide RNAi
screen identifies human host factors crucial for influenza virus
replication. Nature 2010, 463 (7282), 818–822.
(56) George, C. X.; Li, Z.; Okonski, K. M.; Toth, A. M.; Wang, Y.; Samuel,
C. E. Tipping the balance: antagonism of PKR kinase and ADAR1
deaminase functions by virus gene products. J. Interferon Cytokine
Res. 2009, 29 (9), 477–487.
(57) Tenoever, B. R.; Ng, S. L.; Chua, M. A.; McWhirter, S. M.; Garcia-
Sastre, A.; Maniatis, T. Multiple functions of the IKK-related kinase
IKKepsilon in interferon-mediated antiviral immunity. Science
2007, 315 (5816), 1274–1278.
(58) Ngamurulert, S.; Limjindaporn, T.; Auewaraku, P. Identification
of cellular partners of Influenza A virus (H5N1) non-structural
protein NS1 by yeast two-hybrid system. Acta Virol. 2009, 53 (3),
153–159.
(59) Borer, R. A.; Lehner, C. F.; Eppenberger, H. M.; Nigg, E. A. Major
nucleolar proteins shuttle between nucleus and cytoplasm. Cell
1989, 56 (3), 379–390.
(60) Reiner, R.; Krasnov-Yoeli, N.; Dehtiar, Y.; Jarrous, N. Function and
assembly of a chromatin-associated RNase P that is required for
efficient transcription by RNA polymerase I. PLoS One 2008, 3 (12),
e4072.
(61) Jarrous, N.; Reiner, R.; Human RNase, P. a tRNA-processing
enzyme and transcription factor. Nucleic Acids Res. 2007, 35 (11),
3519–3524.
(62) Munday, D.; Emmott, E.; Surtees, R.; Lardeau, C.-H.; Wu, W.;
Duprex, W. P.; Dove, B. K.; Barr, J. N.; Hiscox, J. A. Quantitative
proteomic analysis of A549 cells infected with human respiratory
syncytial virus. Mol. Cell. Proteomics 2010, DOI: 10.1074/mcp.
M110.001859.
(63) Reed, M. L.; Dove, B. K.; Jackson, R. M.; Collins, R.; Brooks, G.;
Hiscox, J. A. Delineation and modelling of a nucleolar retention
signal in the coronavirus nucleocapsid protein. Traffic 2006, 7 (7),
833–848.
research articles Emmott et al.
5344 Journal of Proteome Research • Vol. 9, No. 10, 2010
(64) Cawood, R.; Harrison, S. M.; Dove, B. K.; Reed, M. L.; Hiscox, J. A.
Cell cycle dependent nucleolar localization of the coronavirus
nucleocapsid protein. Cell Cycle 2007, 6 (7), 863–867.
(65) Matthews, D. A. Adenovirus protein V induces redistribution of
nucleolin and B23 from nucleolus to cytoplasm. J. Virol. 2001, 75
(2), 1031–1038.
(66) Lee, T. W. R.; Lawrence, F. J.; Dauksaite, V.; Blair, G. E.; Akusja¨rvi,
G.; Matthews, D. A. Precursor of Adenovirus core polypeptide Mu
targets the nucleolus, modulates the expression of E2 proteins and
alters splice site selection of E1A pre-mRNA in vitro. J. Gen. Virol.
2004, 85, 185–196.
(67) Lee, T. W.; Blair, G. E.; Matthews, D. A. Adenovirus core protein
VII contains distinct sequences that mediate targeting to the
nucleus and nucleolus, and colocalization with human chromo-
somes. J. Gen. Virol. 2003, 84, 3423–3428.
(68) Matthews, D. A.; Russell, W. C. Adenovirus core protein V is
delivered by the invading virus to the nucleolus of the infected
cell and later in infection is associated with nucleoli. J. Gen. Virol.
1998, 79, 1031–1038.
(69) Bicknell, K. A.; Brooks, G.; Kaiser, P.; Chen, H.; Dove, B. K.;
Hiscox, J. A. Nucleolin is regulated both at the level of
transcription and translation. Biochem. Biophys. Res. Commun.
2005, 332, 817–822.
PR100593G
Nucleolar Proteome in Influenza A Virus-Infected Cells research articles
Journal of Proteome Research • Vol. 9, No. 10, 2010 5345
